COLLEYVILLE, TX -- (MARKET WIRE) -- 10/17/07 -- digiMedical Solutions, Inc. (PINKSHEETS: DGMS) today announced the company has developed and deployed a new, proprietary Microsoft .Net based Accounts Receivable (AR) accounting system named digiAccounting 1.0. This new system interfaces with the legacy systems from the company's five existing pharmacies and converts the data into usable and transmittable data for accounting purposes, as a key part of the company's cost-reduction strategy.

digiAccounting has been developed and deployed prior to the Company's anticipated completion of two transactions with financial institutions in order to streamline and digitize the flow of financials across the company's five pharmacies and with the two financial institutions. This new addition to digiMedical's suite of proprietary software is the continuation of digiMedical's business plan to become the premier digital pharmacy chain and provider of digital prescription services in the United States.

digiMedical Solutions, a Microsoft Partner, has built its own suite of proprietary software to handle prescriptions digitally from the physician's office to the pharmacy, securely and in compliance with all DEA and HIPAA requirements. The suite of software includes digiRX, digiRxStream, digiReauth, digiRxComp, and now digiAccounting. This suite is designed to take a standard pharmacy and convert it to a "digital pharmacy." Additionally, the company owns and operates five pharmacies throughout Texas and Florida.

To find out more about digiMedical and our products and services, please visit the company's newly updated website at www.digimedical.com.

To be added to digiMedical's corporate e-mail list for shareholders and interested investors, please send an e-mail to ir@digimedical.com.

About digiMedical Solutions, Inc.™ (www.digiMedical.com)

digiMedical Solutions, Inc.™ is a pharmacy and medical technology company focused on developing next generation, digital medical technology with an emphasis on digital prescriptions (d-Prescriptions) that closely align the doctor, pharmacist and patient. The company's planned growth will come from three channels: direct marketing of the company's wireless based d-prescription technology to physicians, acquisition of independent pharmacy chains and the sale of select territories to "market partners'' licensed to exploit the digiMedical Solutions™ model. digiMedical Solutions, Inc.™ currently owns and operates six pharmacies throughout Texas and Florida and is a Microsoft Independent Software Vendor (ISV). digiMedical Solutions™ unique business model connects physicians, patients and pharmacies with next generation medical technologies.

Forward-Looking Statement

Statements included in this press release which are not historical in nature, are intended to be, and are hereby identified as "Forward-Looking Statements" for purposes of safe harbor provided by Section 21E of the Securities Exchange Act of 1934, as amended. Forward-Looking Statements may be identified by words including "anticipate," "await," "envision," "foresee," "aim at," "believe," "intends," "estimates" including without limitation, those relating to the company's future business prospects, are subject to certain risks and uncertainties that could cause actual results to differ materially from those indicated in the Forward-Looking Statements. Readers are directed to the company's filings with the U.S. Securities and Exchange Commission for additional information and a presentation of the risks and uncertainties that may affect the company's business and results of operations.

Contact:
digiMedical Solutions, Inc.
Investor Relations
Whitney Price
214-722-3029
ir@digimedical.com